Ciprocin-Vet®

Each ml injection contains Ciprofloxacin BP 50 mg.

Livestock:

Route of Administration: IM or IV injection.

Or as directed by the Veterinarian.

Ciprofloxacin administered together with theophylline can lead to elevated blood levels of theophylline. Ciprofloxacin can enhance the action of the anticoagulant warfarin and increase the risk of bleeding.

Patients receiving Ciprocin Vet injection should be well hydrated and should be instructed to drink fluids liberally. Because of the risk of crystalluria, it is recommended that the usual dosage of the drug should not be exceeded. Patients with a history of hypersensitivity to Ciprofloxacin or to other quinolones.

Ciprofloxacin is a time-tested and clinically well-tolerated antibiotic. However, common reactions may include central nervous system (CNS) toxicity, gastrointestinal reactions, hematuria, hepatotoxicity, hypersensitivity reactions, and Stevens–Johnson syndrome (blistering, itching, skin loosening, peeling, or redness), with possible diarrhoea.

Intravenous doses of ciprofloxacin of up to 20 mg per kg of body weight (mg/kg) in pregnant rats and mice have not shown evidence of maternal toxicity, embryotoxicity, or teratogenic effects. Ciprofloxacin can be distributed into milk, sometimes at a higher concentration than in plasma, but it is not known under what conditions significant amounts might be absorbed by nursing animals.

It should be used with caution in patients with suspected or known CNS disorders. Store in a cool and dry place, out of reach of children. Protect from light and moisture. To be dispensed only on the prescription of a registered veterinary doctor.

Store below 30°C in a cool and dry place. Protect from direct sunlight. Keep all medicines out of reach of children.